Buch
The Microbiome in Respiratory Disease
-Principles, Tools and Applications-Yvonne Huang; Stavros Garantziotis (Hrsg.)
160,49
EUR
Lieferzeit 12-13 Tage
Übersicht
Verlag | : | Springer International Publishing |
Buchreihe | : | Respiratory Medicine |
Sprache | : | Englisch |
Erschienen | : | 01. 01. 2022 |
Seiten | : | 273 |
Einband | : | Gebunden |
Höhe | : | 235 mm |
Breite | : | 155 mm |
ISBN | : | 9783030871031 |
Sprache | : | Englisch |
Autorinformation
Dr. Huang is Assistant Professor in the Division of Pulmonary/Critical Care Medicine at the University of Michigan. She has directed numerous respiratory microbiome investigations of asthma and COPD, including NIH multi-center studies.  Her research laboratory utilizes interdisciplinary approaches to understand how the compositional structure and functions of airway and gut microbiota affect airway disease phenotype.  Dr. Huang has served on numerous panels and committees regarding microbiome science and respiratory disease, including for the National Academy of Science, Engineering and Medicine. Dr. Garantziotis is Staff Clinician, Principal Investigator and Medical Director of the Clinical Research Unit at the National Institute of Environmental Health Sciences. His research focuses on gene-environment interactions in the pathogenesis of lung disease. He is leading a number of studies on the role of the microbiome in lung injury and is the Chairperson ofthe working group “Microbiome in Lung Disease” of the American Thoracic Society, Allergy, Immunology and Inflammation Assembly.
Inhaltsverzeichnis
SECTION I: Principles and Tools of Respiratory Microbiome Investigation.- Conceptual Framework and Hypothesis Testing.- Study Design and Sampling Considerations.- Laboratory Platforms to Study the Microbiome.- Analysis and Reporting of Microbiome Data.- SECTION II: Applications in the Study of Specific Diseases.- Chronic Rhinosinusitis /Allergic Rhinitis.- Bronchiolitis, Viral Infection and Pediatric Asthma Risk.- Asthma Pheotype.- Cystic Fibrosis.- Bronchiectasis (non-CF).- COPD.- Idiopathic Pulmonary Fibrosis.- Lung Transplantation and Immune Suppression.- The Future: Knowledge gaps and priorities.